<DOC>
	<DOCNO>NCT00686855</DOCNO>
	<brief_summary>The purpose research study determine effectiveness topical steroid therapy ( drug call dexamethasone ) topical tacrolimus therapy treatment oral chronic Graft-Versus-Host Disease ( cGVHD )</brief_summary>
	<brief_title>Topical Dexamethasone Tacrolimus Treatment Oral Chronic Graft-Versus-Host Disease</brief_title>
	<detailed_description>- Because one know study option best , participant `` randomize '' one two study group : topical dexamethasone topical tacrolimus . - Participants take medication mouth rinse four time day 5 minute time . After rinse spit medication able eat drink 15 minute . - Participants also take anti-fungal medication ( fluconazole ) orally week . - After two week study treatment , participant blood drawn monitor tacrolimus level . - After final treatment ( 4 week ) , participant follow test procedure : clinical examination ; questionnaire ; blood test ; oral culture ; optional tissue biopsy .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients oral chronic graftversushost disease Patients 4 year age older Stable cGVHD medication regimen four week prior study enrollment Patients already topical steroid tacrolimus therapy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>oral rinse</keyword>
</DOC>